Baxter International Inc (MIL:1BAX)
€ 32.01 0 (0%) Market Cap: 14.28 Bil Enterprise Value: 25.64 Bil PE Ratio: 145.90 PB Ratio: 1.89 GF Score: 45/100

Baxter International Inc at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 06:30PM GMT
Release Date Price: €35.05
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Welcome, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Really happy to have our next session with Baxter International. I'm going to bring up Joe Almeida, the CEO, for a presentation and then we'll do some Q&A after. Joe?

Jose E. Almeida
Baxter International Inc. - Chairman of the Board, President & CEO

Good morning. Thanks for attending the Baxter JPMorgan conference presentation. Please read our safe harbor statement. This is also on our website. This presentation is going to be posted there as well.

We are -- about a year ago, we set forth a transformation mission for Baxter, and we've been very active in pursuing that. I'm going to give an update where we are today and tell you how much progress we've made and how excited we are about the future in 2024.

Baxter touches about 350 million patients a year across the globe, it's one of the largest health care companies in terms of interaction with patients, not only in the home but also in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot